Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients

NCT01658839 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost ophthalmic solution, 0.004% (new formulation)

Sponsor

Alcon Research